This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 1978-2002.
Company Filing History:
Years Active: 1978-2002
Title: The Innovations of Paul C Watts
Introduction
Paul C Watts is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastroduodenal diseases. With a total of 6 patents to his name, his work has the potential to impact many lives.
Latest Patents
Among his latest patents is a compound for treating gastroduodenal diseases known as Spirolaxine. This compound, represented by the formula (I) where R is H, along with novel compounds where R is (C-C) alkyl or CH(CH)CO, is useful in treating conditions such as gastric ulcers, duodenal ulcers, and gastric cancer. Spirolaxine and its methyl ether are isolated from the fermentation of ATCC 74278. Additionally, Spirolaxine and the compounds of formula (I) can be used in combination with H antagonists, colloidal bismuth subcitrate, and other antibiotics.
Career Highlights
Paul C Watts has had a distinguished career, primarily working with Pfizer Corporation. His innovative research and development efforts have led to advancements in medical treatments, particularly in gastroenterology.
Collaborations
Throughout his career, Paul has collaborated with esteemed colleagues such as Walter D Celmer and Walter P Cullen. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
In summary, Paul C Watts is a prominent inventor whose work in the pharmaceutical industry has led to significant advancements in treating gastroduodenal diseases. His contributions continue to pave the way for innovative solutions in healthcare.